HIGHLIGHTS
- who: Adviti Naik from the University of Texas MD Anderson Cancer Center, United States have published the research: Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets, in the Journal: (JOURNAL) of 20/Oct/2022
- what: Within the area of CTA biomarkers, the study by Peng et_al focuses on the biomarker value of LDHC in serum and exosomes of lung adenocarcinoma patients.
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.